Align Technology (NASDAQ:ALGN) Shares Gap Up – What’s Next?

Align Technology, Inc. (NASDAQ:ALGN) gapped up before the market opened on Thursday . The stock had previously closed at $172.41, but opened at $180.00. Align Technology shares last traded at $178.6940, with a volume of 645,187 shares traded.

Key Align Technology News

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Elliott Investment Management has built a significant/activist stake in Align, which investors expect could push for strategic actions (cost cuts, capital returns, M&A or other value-enhancing moves). Activist involvement often acts as a near-term catalyst for underperforming names. Elliott builds stake – Reuters
• Positive Sentiment: Barclays upgraded ALGN to Overweight and set a higher price target, citing improved valuation after the stock’s pullback — that fresh analyst support can attract buyers and institutional flows. Barclays upgrade – Seeking Alpha
• Neutral Sentiment: Align’s strategic partnerships and product positioning in digital dentistry (e.g., involvement in SprintRay’s “Midas” education program) support the company’s long-term TAM and stickiness of iTero scanners, but these are longer-term fundamentals rather than immediate catalysts. SprintRay collaboration – Yahoo
• Neutral Sentiment: Several outlets and aggregators are highlighting rising momentum indicators and institutional interest; these technical/flow signals can reinforce the move but don’t change underlying fundamentals. (Multiple press/quote sources consolidated).
• Negative Sentiment: Underlying revenue growth has slowed from pandemic-era peaks as cosmetic demand normalized; that’s the root reason Elliott is likely pressing for changes — an operational headwind that could constrain upside absent successful execution of new initiatives. Weaker demand context – Benzinga

Analysts Set New Price Targets

Several equities analysts have issued reports on ALGN shares. Morgan Stanley lifted their target price on Align Technology from $154.00 to $169.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. Piper Sandler raised their price target on shares of Align Technology from $200.00 to $220.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Barclays raised shares of Align Technology from an “equal weight” rating to an “overweight” rating and set a $200.00 price objective on the stock in a research report on Tuesday. Stifel Nicolaus boosted their price objective on shares of Align Technology from $200.00 to $210.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Finally, Evercore increased their target price on shares of Align Technology from $180.00 to $200.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Seven investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $198.08.

Align Technology Trading Up 3.2%

The company has a 50-day moving average of $176.43 and a 200-day moving average of $153.90. The company has a market capitalization of $12.68 billion, a price-to-earnings ratio of 31.47, a price-to-earnings-growth ratio of 1.92 and a beta of 1.79.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share for the quarter, topping the consensus estimate of $2.99 by $0.30. Align Technology had a return on equity of 15.16% and a net margin of 10.17%.The business had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter last year, the company earned $2.44 earnings per share. The company’s quarterly revenue was up 5.3% on a year-over-year basis. On average, research analysts expect that Align Technology, Inc. will post 7.98 EPS for the current year.

Insider Buying and Selling

In other Align Technology news, EVP John Morici sold 7,969 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $189.31, for a total transaction of $1,508,611.39. Following the sale, the executive vice president owned 8,237 shares of the company’s stock, valued at approximately $1,559,346.47. The trade was a 49.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.66% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Capital International Investors lifted its stake in shares of Align Technology by 52.2% during the fourth quarter. Capital International Investors now owns 4,643,221 shares of the medical equipment provider’s stock worth $725,039,000 after buying an additional 1,592,848 shares during the period. Holocene Advisors LP acquired a new position in shares of Align Technology in the 3rd quarter valued at $179,035,000. Ruane Cunniff & Goldfarb L.P. purchased a new position in Align Technology in the 4th quarter worth $190,899,000. Norges Bank purchased a new position in Align Technology in the 4th quarter worth $155,556,000. Finally, Arrowstreet Capital Limited Partnership lifted its position in Align Technology by 247.3% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,005,413 shares of the medical equipment provider’s stock worth $156,995,000 after acquiring an additional 715,919 shares during the period. Hedge funds and other institutional investors own 88.43% of the company’s stock.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.